GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Suzhou Highfine Biotech Co Ltd (SZSE:301393) » Definitions » Long-Term Debt

Suzhou Highfine Biotech Co (SZSE:301393) Long-Term Debt : ¥0.0 Mil (As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Suzhou Highfine Biotech Co Long-Term Debt?

Suzhou Highfine Biotech Co's Long-Term Debt for the quarter that ended in Sep. 2024 was ¥0.0 Mil.

Suzhou Highfine Biotech Co Long-Term Debt Historical Data

The historical data trend for Suzhou Highfine Biotech Co's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Suzhou Highfine Biotech Co Long-Term Debt Chart

Suzhou Highfine Biotech Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Long-Term Debt
Get a 7-Day Free Trial - - - - -

Suzhou Highfine Biotech Co Quarterly Data
Dec18 Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Suzhou Highfine Biotech Co  (SZSE:301393) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Suzhou Highfine Biotech Co Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Suzhou Highfine Biotech Co's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Suzhou Highfine Biotech Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Suzhou Highfine Biotech Co Ltd (SZSE:301393) » Definitions » Long-Term Debt
Comparable Companies
SHSE:688566 SHSE:600488 SHSE:688176 SHSE:600829 SHSE:603207 SZSE:002393 SHSE:600351 SHSE:688247 BJSE:830946 SHSE:600479 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ XTAE:TEVA NSE:DIVISLAB HKSE:03692
Traded in Other Exchanges
N/A
Address
No. 32 Hongxi Road, F-12 Standard Factory Building, High-tech Zone, Jiangsu Province, Suzhou, CHN, 215151
Website
https://www.highfine.com
Suzhou Highfine Biotech Co Ltd is a high-tech enterprise that provides characteristic raw materials for global pharmaceutical research and development and raw material drug production companies. The products are mainly used in the fields of peptide, nucleotide and pharmaceutical synthesis. The product range covers peptide synthesis reagents for characteristic amide bond formation, molecular building blocks, protein reagents, liposome and lipid nanoparticle pharmaceutical reagents, ionic liquids , PROTAC reagents and nucleotide reagents and other types.
Executives
Dong Sheng Jun Directors, executives
Lu Xue Gen Directors, executives
Lv Min Jie Directors, executives
Xu Jie Directors, executives

Suzhou Highfine Biotech Co Headlines

No Headlines